217 related articles for article (PubMed ID: 36969161)
21. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
22. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
[TBL] [Abstract][Full Text] [Related]
23. Prognosis, immune microenvironment, and personalized treatment prediction in Rho GTPase-activating protein 4-mutant cervical cancer: Computer strategies for precision oncology.
Lu X; Ying Y; Zhang W; Zhang J; Li R; Wang W
Life Sci; 2023 Feb; 315():121360. PubMed ID: 36608869
[TBL] [Abstract][Full Text] [Related]
24. Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures.
Wang N; Nanding A; Jia X; Wang Y; Yang C; Fan J; Dong A; Zheng G; Ma J; Shi X; Yang Y
Front Immunol; 2022; 13():993118. PubMed ID: 36341424
[TBL] [Abstract][Full Text] [Related]
25. Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Data to Explore the Key Role of Fatty Acid Metabolism in Breast Cancer.
Chen Y; Wu W; Jin C; Cui J; Diao Y; Wang R; Xu R; Yao Z; Li X
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686016
[TBL] [Abstract][Full Text] [Related]
26. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
27. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
28. SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
Xia QD; Sun JX; Xun Y; Xiao J; Liu CQ; Xu JZ; An Y; Xu MY; Liu Z; Wang SG; Hu J
Front Immunol; 2022; 13():864156. PubMed ID: 35418978
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Immune Microenvironmental Landscape of Lung Squamous Cell Carcinoma with Immune Cell Infiltration.
Chen C; Tang D; Gu C; Wang B; Yao Y; Wang R; Zhang H; Gao W
Dis Markers; 2022; 2022():2361507. PubMed ID: 36411824
[TBL] [Abstract][Full Text] [Related]
30. Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer.
Chen F; Shen L; Wang Y; Chen Y; Pan X; Liang H; Yu H
Aging (Albany NY); 2023 Mar; 15(5):1685-1698. PubMed ID: 36917087
[TBL] [Abstract][Full Text] [Related]
31. Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.
Wen Y; Zhang S; Yang J; Guo D
Biomed Pharmacother; 2019 Dec; 120():109546. PubMed ID: 31675687
[TBL] [Abstract][Full Text] [Related]
32. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
33. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
34. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
35. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer.
Wu W; Wang X; Le W; Lu C; Li H; Zhu Y; Chen X; An W; Xu C; Wu Q; Wang L
Front Immunol; 2022; 13():1001297. PubMed ID: 36700224
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
37. Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment.
Zhang L; Wang S; Wang Y; Zhao W; Zhang Y; Zhang N; Xu H
Front Immunol; 2021; 12():645320. PubMed ID: 33737938
[TBL] [Abstract][Full Text] [Related]
38. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
39. Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
Yu S; Li X; Zhang J; Wu S
Front Immunol; 2021; 12():709493. PubMed ID: 34539641
[TBL] [Abstract][Full Text] [Related]
40. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
